J&J buying into maker of vaccines

(STAR LEDGER) — Johnson & Johnson wants to add something new to its medicine cabinet: a vaccine to prevent and treat multiple strains of influenza.

In a deal announced yesterday, the New Brunswick-based health care giant said it would acquire an 18 percent stake in the Dutch vaccine-maker Crucell and immediately begin collaborating on a universal monoclonal antibody product for preventing and treating different strains of influenza A, including H1N1 (swine flu) and H5N1 (avian flu).

via J&J buying into maker of vaccines | New Jersey Business – – NJ.com .

Be the first to comment

Leave a Reply

Your email address will not be published.